ATLANTA, July 18, 2018 /PRNewswire/ -- Alimera
Sciences (NASDAQ: ALIM), a leader in the commercialization and
development of prescription ophthalmic pharmaceuticals, today
announced that it will release its financial results for the second
quarter ended June 30, 2018, after
the close of the financial markets on Monday, July 30, 2018.
An accompanying conference call will be hosted by Dan Myers, Chief Executive Officer and
Rick Eiswirth, President and Chief
Financial Officer to discuss the results. The call will be held at
9:00 AM ET, on Tuesday, July 31, 2018. Please refer to the
information below for conference call dial-in information and
webcast registration.
Conference Details
Conference date: Tuesday July 31,
2018 9:00 AM ET
Conference dial-in: 877.269.7756
International dial-in: 201.689.7817
Conference Call Name: Alimera Sciences Second Quarter 2018
Results Call
Webcast Registration: Click Here
Following the live call, a replay will be available on the
Company's website, www.alimerasciences.com, under "Investor
Relations."
About Alimera Sciences
Alimera, founded in June 2003, is
a pharmaceutical company that specializes in the commercialization
and development of prescription ophthalmic pharmaceuticals. Alimera
is presently focused on diseases affecting the back of the eye, or
retina because these diseases are not well treated with current
therapies and will affect millions of people in our aging
populations. Alimera's commitment to retina specialists and their
patients is manifest in Alimera's product portfolio. For more
information, please visit www.alimerasciences.com.
For press
inquiries:
Katie
Brazel
for Alimera
Sciences
404-317-8361
kbrazel@bellsouth.net
|
For investor
inquiries:
CG Capital
for Alimera
Sciences
877-889-1972
investorrelations@cg.capital
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/alimera-sciences-to-report-second-quarter-2018-results-july-30-2018-300682692.html
SOURCE Alimera Sciences, Inc.